Trial intelligence / Profile preview

Levosimendan for Diaphragm Function in Weaning

NCT01721434Phase 3Unknown

Sponsor
Radboud University Medical Center
Start
Sep 2012
Primary completion
May 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in diaphragm dysfunction and Weaning failure comparing Levosimendan with Placebo (2 arms). Primary endpoint: Neuro-mechanical efficiency of the diaphragm. Status: unknown.

02

Drugs

levosimendan
03

Conditions

diaphragm dysfunctionWeaning failure

Beyond the preview

Go deeper on NCT01721434.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01721434.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call